Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 41% ± 19% | |
pericyte | 7 studies | 37% ± 17% | |
smooth muscle cell | 5 studies | 33% ± 12% | |
conventional dendritic cell | 4 studies | 18% ± 3% |
Insufficient scRNA-seq data for expression of DBNDD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 18008.31 | 2642 / 2642 | 89% | 3.92 | 628 / 705 |
intestine | 100% | 6683.36 | 964 / 966 | 79% | 2.40 | 415 / 527 |
stomach | 89% | 3438.85 | 320 / 359 | 86% | 2.54 | 246 / 286 |
esophagus | 98% | 5475.49 | 1419 / 1445 | 67% | 1.59 | 123 / 183 |
breast | 98% | 3120.91 | 448 / 459 | 49% | 1.35 | 549 / 1118 |
uterus | 99% | 5438.09 | 168 / 170 | 48% | 1.24 | 219 / 459 |
bladder | 100% | 6132.86 | 21 / 21 | 45% | 1.28 | 228 / 504 |
ovary | 59% | 1571.36 | 106 / 180 | 77% | 1.96 | 329 / 430 |
lung | 99% | 3269.59 | 570 / 578 | 33% | 0.60 | 376 / 1155 |
prostate | 96% | 3897.17 | 236 / 245 | 31% | 0.51 | 158 / 502 |
adrenal gland | 53% | 1001.99 | 136 / 258 | 56% | 1.52 | 128 / 230 |
thymus | 88% | 1960.22 | 574 / 653 | 12% | 0.21 | 75 / 605 |
blood vessel | 100% | 10334.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7440.87 | 803 / 803 | 0% | 0 | 0 / 0 |
pancreas | 28% | 518.48 | 92 / 328 | 72% | 1.52 | 128 / 178 |
heart | 99% | 10593.61 | 852 / 861 | 0% | 0 | 0 / 0 |
adipose | 97% | 3237.15 | 1166 / 1204 | 0% | 0 | 0 / 0 |
kidney | 66% | 1539.58 | 59 / 89 | 30% | 0.56 | 270 / 901 |
skin | 72% | 2179.87 | 1301 / 1809 | 7% | 0.10 | 31 / 472 |
spleen | 63% | 1182.02 | 152 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.35 | 8 / 29 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.32 | 8 / 45 |
liver | 0% | 10.58 | 1 / 226 | 7% | 0.13 | 29 / 406 |
peripheral blood | 6% | 102.92 | 52 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | DBNDD2 |
Protein name | Dysbindin domain containing 2 Dysbindin domain-containing protein 2 (Casein kinase-1 binding protein) (CK1BP) (HSMNP1) |
Synonyms | C20orf35 |
Description | FUNCTION: May modulate the activity of casein kinase-1. Inhibits CSNK1D autophosphorylation (in vitro). . |
Accessions | ENST00000360981.8 [Q9BQY9-2] ENST00000443296.1 ENST00000372722.7 [Q9BQY9-3] ENST00000357275.6 [Q9BQY9-2] H0Y7N7 ENST00000372712.6 [Q9BQY9-2] ENST00000372717.5 [Q9BQY9-3] ENST00000372710.5 [Q9BQY9-2] ENST00000372723.7 [Q9BQY9-2] Q9BQY9 ENST00000372720.7 [Q9BQY9-1] |